---
title: "MapLight Therapeutics names Martin Babler, Troy Cox to board of directors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290683102.md"
description: "MapLight Therapeutics appointed Martin Babler and Troy Cox to its board of directors following the June 23 annual meeting. Babler, CEO of Alumis, joined the audit committee, while Cox, former Foundation Medicine CEO, chairs the nominating and corporate governance committee. They replaced Robert Malenka and Jim Trenkle, who did not stand for re-election."
datetime: "2026-06-24T11:01:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290683102.md)
  - [en](https://longbridge.com/en/news/290683102.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290683102.md)
---

# MapLight Therapeutics names Martin Babler, Troy Cox to board of directors

-   MapLight Therapeutics added Martin Babler and Troy Cox to its board following their election at the June 23 annual meeting. \* Babler, CEO and chairman of Alumis since September 2021, joined the audit committee; he previously led Principia Biopharma. \* Cox, former Foundation Medicine CEO (2017-2019), became chair of the nominating and corporate governance committee; he previously held senior roles at Genentech. \* They replaced Robert Malenka and Jim Trenkle, who did not stand for re-election and have left the board. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606240700PRIMZONEFULLFEED9751749) on June 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [MPLT.US](https://longbridge.com/en/quote/MPLT.US.md)
- [ALMS.US](https://longbridge.com/en/quote/ALMS.US.md)

## Related News & Research

- [Maplight Therapeutics director Troy Cox reports purchase of 15,620 shares worth $148,702.4](https://longbridge.com/en/news/294132686.md)
- [Maplight Therapeutics (NASDAQ:MPLT) Director Acquires $148,702.40 in Stock](https://longbridge.com/en/news/294144422.md)
- [MapLight says Phase 2 ZEPHYR trial shows ML-007C-MA cuts PANSS score in schizophrenia](https://longbridge.com/en/news/293920685.md)
- [MapLight Therapeutics, Inc. (MPLT) Gets a Buy from Jefferies](https://longbridge.com/en/news/294388175.md)
- [Bicara Therapeutics names Jeremy Bender, Christy Oliger to board](https://longbridge.com/en/news/294066260.md)